(Q24246891)

English

Monoamine oxidase B inhibitors for early Parkinson's disease

scientific article (publication date: 19 July 2004)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Monoamine oxidase B inhibitors for early Parkinson's disease (English)

0 references

1 reference

AD Macleod

1

0 references

CE Counsell

series ordinal

2

0 references

N Ives

series ordinal

3

0 references

R Stowe

series ordinal

4

0 references

publication date

19 July 2004

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Selegiline, or the problem of early termination of clinical trials. The clinical questions are not well answered, and probably never will be.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Selegiline in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Parkinson's disease. Second of two parts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Selegiline: current perspectives on issues related to neuroprotection and mortality

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Systematic review of incidence studies of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

The role of dopamine agonists in early Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

21 January 2018

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004898

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD004898

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2509785

Fatcat ID

release_uykd5sjtzrap7a53nswlp7x6k4

0 references

OpenCitations bibliographic resource ID

2509785

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2509785

(Q24246891)

Monoamine oxidase B inhibitors for early Parkinson's disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)